GAL-201

N/A

Report date: 2024/11/15 17:02:26
NME

Base Information

Drug NameGAL-201
Drug Alias NameGAL-201
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta amyloid A4 protein modulators
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRamot At Tel Aviv University
China Registration ClassN/A

Develop Information

Active CompaniesGalimedix Therapeutics IncRamot At Tel Aviv University
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A